Works matching IS 15257304 AND DT 2018 AND VI 19 AND IP 5
Results: 46
RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell Lines.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ultracentral Tumors Treated With Stereotactic Body Radiotherapy: Single-Institution Experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
ROS1-Rearranged Non-Small-Cell Lung Cancer, Factor V Leiden, and Recurrent Venous Thromboses.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Chemoradiotherapy in Elderly Patients With Non-Small-Cell Lung Cancer: Long-Term Follow-Up of a Randomized Trial (JCOG0301).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Incidental Pulmonary Malignancies on CTAC in MPS.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Characteristics and Prognosis of Patients With Advanced Non-Small-cell Lung Cancer Who Are Ineligible for Clinical Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ventana ALK (D5F3) in the Detection of Patients Affected by Anaplastic Lymphoma Kinase-positive Non-Small-cell Lung Cancer: Clinical and Budget Effect.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Screening Patterns and Mortality Differences in Patients With Lung Cancer at an Urban Underserved Community.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Patient-Reported Outcomes in OAK: A Phase III Study of Atezolizumab Versus Docetaxel in Advanced Non-Small-cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comparing Outcomes of Patients With Early-Stage Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Frailty Status.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Risk Factors of Recurrence in Patients With Clinical Stage IA Adenocarcinoma Presented as Ground-Glass Nodule.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Lung Cancers Detected on Computed Tomography Attenuation Correction Images During Myocardial Perfusion Scintigraphy.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Nivolumab-induced Limbic Encephalitis with Anti-Hu Antibody in a Patient With Advanced Pleomorphic Carcinoma of the Lung.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rationale and Protocol for a Canadian Multicenter Phase II Randomized Trial Assessing Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-small-cell Lung Cancer (NCT02788461).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Phase II Trial of First-Line Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Unresectable Malignant Pleural Mesothelioma: A Study Protocol.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Characterization of Computed Tomography Imaging of Rearranged During Transfection-rearranged Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Molecular Testing Turnaround Time in Non-Small-Cell Lung Cancer: Monitoring a Moving Target.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evaluation of a Dual ALK/ROS1 Fluorescent In Situ Hybridization Test in Non-Small-cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase Ib Study of High-dose Intermittent Afatinib in Patients With Advanced Solid Tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Widespread Nivolumab-induced Enteropathy in a Long Responder Non-Small-cell Lung Cancer Patient.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Programmed Cell Death Ligand 1 Expression in Non-Small-cell Lung Cancer Patients With Interstitial Lung Disease: A Matched Case-control Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Surgically Treated Unsuspected N2-Positive NSCLC: Role of Extent and Location of Lymph Node Metastasis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Docetaxel Down-Regulates PD-1 Expression via STAT3 in T Lymphocytes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Significance of Spread Through Air Spaces in Resected Lung Adenocarcinomas With Lymph Node Metastasis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Primary Thoracic Cancers Incidentally Detected on CT Attenuation Correction Images During Myocardial Perfusion Scintigraphy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Toward a Molecular Diagnosis in a Single Day for Patients With Advanced Non-small-cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Recurrent Pericardial Effusion While Receiving Nivolumab for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comparing Treatment Strategies for Stage I Small-cell lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung Adenocarcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Tumor Microenvironment Properties are Associated With Low CD68-positive Cell Infiltration and Favorable Disease-free Survival in EGFR-mutant Lung Adenocarcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Decade of Never-smokers Among Lung Cancer Patients-Increasing Trend and Improved Survival.
- Published in:
- 2018
- By:
- Publication type:
- journal article